Table 2.
Factor | Model | AUC | Sensitivity | Specificity | Precision | F1-score | npv | Cutoff |
---|---|---|---|---|---|---|---|---|
Cholesterol | MassVol | 0.587 | 0.704 | 0.451 | 0.346 | 0.464 | 0.787 | 0.495 |
PCA50* | 0.751 | 0.792 | 0.579 | 0.437 | 0.564 | 0.871 | 0.485 | |
Smoking | MassVol | 0.594 | 0.856 | 0.287 | 0.334 | 0.480 | 0.826 | 0.490 |
PCA50* | 0.699 | 0.525 | 0.795 | 0.517 | 0.521 | 0.800 | 0.511 | |
Diabetes | MassVol | 0.652 | 0.740 | 0.554 | 0.342 | 0.468 | 0.872 | 0.494 |
PCA50* | 0.817 | 0.704 | 0.781 | 0.502 | 0.586 | 0.894 | 0.504 | |
Previous MI | MassVol | 0.733 | 0.699 | 0.663 | 0.235 | 0.351 | 0.937 | 0.490 |
PCA50* | 0.853 | 0.677 | 0.911 | 0.529 | 0.594 | 0.950 | 0.518 | |
Angina | MassVol | 0.671 | 0.700 | 0.637 | 0.196 | 0.307 | 0.944 | 0.497 |
PCA50* | 0.773 | 0.663 | 0.763 | 0.262 | 0.376 | 0.947 | 0.493 | |
Obesity | MassVol | 0.682 | 0.675 | 0.598 | 0.638 | 0.656 | 0.637 | 0.494 |
PCA50* | 0.839 | 0.760 | 0.763 | 0.771 | 0.766 | 0.752 | 0.500 | |
Hypertension | MassVol | 0.651 | 0.693 | 0.543 | 0.718 | 0.705 | 0.514 | 0.495 |
PCA50* | 0.770 | 0.752 | 0.663 | 0.789 | 0.770 | 0.615 | 0.494 |
Statistical tests were performed between MassVol and PCA50. Significant differences (p < 0.005) are represented with an asterisk
PCA principal component analysis, MI myocardial infarction